31.12.2014 Views

SENATE - Louisiana

SENATE - Louisiana

SENATE - Louisiana

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Page 40 <strong>SENATE</strong><br />

June 21, 2004<br />

2. That the Senate Floor Amendments proposed by Senator<br />

Marionneaux and adopted by the Senate on June 16, 2004, be<br />

rejected.<br />

3. That the following amendments to the reengrossed bill be<br />

adopted:<br />

AMENDMENT NO. 1<br />

On page 2, line 16, after "Act" delete the comma "," and delete the<br />

remainder of the line and delete line 17 and at the beginning of line 18,<br />

delete "mail"<br />

AMENDMENT NO. 2<br />

On page 2, line 21, after "18:1511.5." insert ""Outstanding fine, fee,<br />

or penalty" shall not mean any fine, fee, or penalty which has been<br />

paid in full or for which the candidate is in compliance with a<br />

payment plan established in writing bet ween the Supervisory<br />

Committee on Campaign Finance Disclosure and the candidate."<br />

Representatives:<br />

Carla Blanchard Dartez<br />

Representative Charles D. Lancaster, Jr.<br />

Representative M.J. "Mert" Smiley<br />

Rules Suspended<br />

Respectfully submitted,<br />

Senators:<br />

Reggie Dupre<br />

Robert Marionneaux, Jr.<br />

Charles D. Jones<br />

Senator Marionneaux asked for and obtained a suspension of the<br />

rules for the purpose of considering the Conference Committee<br />

Report. On motion of Senator Marionneaux, a vote was taken on the<br />

adoption of the report.<br />

ROLL CALL<br />

The roll was called with the following result:<br />

YEAS<br />

Mr. President Duplessis Kostelka<br />

Adley Dupre Lentini<br />

Amedee Ellington Malone<br />

Bajoie Fontenot Marionneaux<br />

Barham Gautreaux, B McPherson<br />

Boasso Gautreaux, N Michot<br />

Boissiere Hainkel Nevers<br />

Cain Heitmeier Romero<br />

Chaisson Holden Smith<br />

Cheek Hollis Theunissen<br />

Cravins Irons Ullo<br />

Dardenne<br />

Jones<br />

Total—35<br />

NAYS<br />

Fields<br />

Total—1<br />

ABSENT<br />

Jackson Mount Schedler<br />

Total—3<br />

50th DAY'S PROCEEDINGS<br />

The Chair declared the Conference Committee Report was<br />

adopted. Senator Marionneaux moved to reconsider the vote by<br />

which the report was adopted and laid the motion on the table.<br />

CONFERENCE COMMITTEE REPORT<br />

House Bill No. 1701 By Representative Durand<br />

June 18, 2004<br />

To the Honorable Speaker and Members of the House of<br />

Representatives and the Honorable President and Members of the<br />

Senate.<br />

Ladies and Gentlemen:<br />

We, the conferees appointed to confer over the disagreement<br />

between the two houses concerning House Bill No. 1701 by<br />

Representative Durand, recommend the following concerning the<br />

engrossed bill:<br />

1. That Senate Floor Amendments Nos. 1 and 2 proposed by<br />

Senator Holden and adopted by the Senate on June 14, 2004, be<br />

adopted.<br />

2. That Senate Floor Amendment No. 3 proposed by Senator<br />

Holden and adopted by the Senate on June 14, be rejected.<br />

3. That the following amendments to the engrossed bill be adopted:<br />

AMENDMENT NO. 1<br />

On page 5, line 17, delete the word "urine"<br />

AMENDMENT NO. 2<br />

On page 6, line 8, delete the word "urine"<br />

AMENDMENT NO. 3<br />

On page 6, line 9, delete the word "urine"<br />

AMENDMENT NO. 4<br />

On page 6, between lines 21 and 22, insert the following:<br />

"J. This Chapter does not preclude an employer or an<br />

employer's agent from utilizing a USFDA cleared specimen testing<br />

method that uses a sample as defined in R.S. 49:1001 provided that<br />

such sample is processed in a laboratory with a SAMHSA<br />

certification using generally accepted cutoff levels as established by<br />

the USFDA for a saliva or oral fluid testing product, or by SAMHSA<br />

at such time when SAMHSA implements a final rule to regulate<br />

saliva or oral fluid testing. Any saliva or oral fluid sample collected<br />

shall be subject to USFDA-cleared immunoassay screening and<br />

confirmation testing at a SAMHSA certified laboratory. Such<br />

samples that test positive shall be preserved by the laboratory and<br />

available for challenge testing at the request of the donor. No sample<br />

shall be used to collect or analyze DNA."<br />

AMENDMENT NO. 5<br />

On page 6, delete line 24 in its entirety<br />

AMENDMENT NO. 6<br />

On page 6, line 25, delete "49:1008," and insert "A. All drug testing"<br />

Respectfully submitted,<br />

2142

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!